Early intensive behavioral intervention (EIBI)

From Pheno Wiki
Revision as of 11:48, 2 November 2010 by Deanna (Talk | contribs)

Jump to: navigation, search

Early intensive behavioral intervention (EIBI)

Basic Characteristics

  • Description

Early Intensive Behavioral Intervention (EIBI) is an intensive, one on one behavioral intervention program that targets children 4 years or younger. Therapy is from 20-40 hours per week, with the best outcome at 40 hours per week. The UCLA model is one well known clinic based EIBI program, with initially reported rates of 47% recovery.1 However, subsequently analysis into the "recovered" group showed that many of the subjects had scores that were significantly below the normal threshold post treatment, and no teacher or parent measures were used in the study to assess "recovery". It is likely that the actual "recovery" rate is much lower than initially reported. 2

EIBI programs are often confused with DTT because early EIBI programs mostly utilized DTT as a structured teaching format. 3

  • History

EIBI is based on principles of learning and motivation, consisting of extinction, stimulus control, and generalization.


Neuroimaging

Concerns

Interventions

Pivotal Response Training Interventions are naturalistic and individualized. There have been no studies which examined outcomes of PRT vs. outcomes of other interventions such as Joint Attention or Symbolic Play






Back to Main Page







References

1.Reichow B. et al. Comprehensive synthesis of early intensive behavioral interventions for young children with autism based on the UCLA young autism project model.J Autism Dev Disord. 2009 Jan;39(1):23-41 PMID 18535894

2. Shea V.A perspective on the research literature related to early intensive behavioral intervention (Lovaas) for young children with autism.Autism. 2004 Dec;8(4):349-67. PMID 15556956

3. Granpeesheh D et. al. Applied behavior analytic interventions for children with autism: a description and review of treatment research.Ann Clin Psychiatry. 2009 Jul-Sep;21(3):162-73. PMID 19758537


Other Details